We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
-3.7%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$648M
AUM Growth
-$9.06M
Cap. Flow
+$24M
Cap. Flow %
3.7%
Top 10 Hldgs %
46.83%
Holding
2,692
New
549
Increased
875
Reduced
655
Closed
135

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$2.72M
2
VUG icon
Vanguard Morningstar Growth ETF
VUG
+$2.15M
3
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$1.97M
4
BXMX
Nuveen S&P 500 Buy-Write Income Fund
BXMX
+$1.82M
5
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$1.78M

Top Sells

Rank Stock Value
1
PFF icon
iShares Preferred and Income Securities ETF
PFF
+$2.13M
2
PGF icon
Invesco Financial Preferred ETF
PGF
+$1.13M
3
NIO icon
NIO
NIO
+$689K
4
IGSB icon
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
+$524K
5
HIX
Western Asset High Income Fund II
HIX
+$516K

Sector Composition

Rank Sector Weight
1 Financials 14.19%
2 Technology 12.41%
3 Healthcare 4.56%
4 Consumer Discretionary 4.33%
5 Industrials 3.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABM icon
1651
ABM Industries
ABM
$2.84B
$4K ﹤0.01%
86
+58
+207% +$2.52K
ACAD icon
1652
Acadia Pharmaceuticals
ACAD
$5.03B
$4K ﹤0.01%
167
+68
+69% +$1.65K
ACRS icon
1653
Aclaris Therapeutics
ACRS
$869M
$4K ﹤0.01%
+208
New +$2.84K
ADC icon
1654
Agree Realty
ADC
$9.41B
$4K ﹤0.01%
54
-69
-56% -$4.49K
AGCO icon
1655
AGCO
AGCO
$7.2B
$4K ﹤0.01%
27
+5
+23% +$631
AGO icon
1656
Assured Guaranty
AGO
$3.34B
$4K ﹤0.01%
64
– –
AMPH icon
1657
Amphastar Pharmaceuticals
AMPH
$916M
$4K ﹤0.01%
105
+29
+38% +$822
ANF icon
1658
Abercrombie & Fitch
ANF
$5B
$4K ﹤0.01%
126
– –
ARRY icon
1659
Array Technologies
ARRY
$855M
$4K ﹤0.01%
+311
New +$3.49K
ASH icon
1660
Ashland
ASH
$3.5B
$4K ﹤0.01%
39
+6
+18% +$577
AX icon
1661
Axos Financial
AX
$5.68B
$4K ﹤0.01%
79
– –
BCC icon
1662
Boise Cascade
BCC
$3.02B
$4K ﹤0.01%
64
+22
+52% +$1.66K
BCRX icon
1663
BioCryst Pharmaceuticals
BCRX
$2.4B
$4K ﹤0.01%
+226
New +$3.63K
BILL icon
1664
BILL Holdings
BILL
$4.78B
$4K ﹤0.01%
17
+9
+113% +$1.88K
BUSE icon
1665
First Busey Corp
BUSE
$2.56B
$4K ﹤0.01%
+158
New +$4.35K
CAC icon
1666
Camden National
CAC
$976M
$4K ﹤0.01%
79
+22
+39% +$1.09K
CADE
1667
DELISTED
Cadence Bank
CADE
$4K ﹤0.01%
137
-5
-4% -$156
CATO icon
1668
Cato Corp
CATO
$66.1M
$4K ﹤0.01%
+284
New +$4.69K
CCRN
1669
DELISTED
Cross Country Healthcare
CCRN
$4K ﹤0.01%
+187
New +$4.06K
CDLX icon
1670
Cardlytics
CDLX
$21.5M
$4K ﹤0.01%
7
+4
+133% +$2.42K
CGC
1671
Canopy Growth
CGC
$410M
$4K ﹤0.01%
47
– –
CLBK icon
1672
Columbia Financial
CLBK
$1.13B
$4K ﹤0.01%
182
+29
+19% +$619
COLL icon
1673
Collegium Pharmaceutical
COLL
$956M
$4K ﹤0.01%
+181
New +$3.42K
DK icon
1674
Delek US
DK
$3.58B
$4K ﹤0.01%
+173
New +$3.14K
DOX icon
1675
Amdocs
DOX
$6.22B
$4K ﹤0.01%
44
+8
+22% +$627
65 66
67
68 69

Similar funds

SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
CIG
CCM Investment Group Northfield, Minnesota $946M AUM
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return

Lindbrook Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Lindbrook Capital held 2,692 positions worth $648M, down 1.4% from $657M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Lindbrook Capital deployed $24M of net new capital in Q1 2022, opening 549 new positions and adding to 875 existing holdings. Its largest new stake was Claros Mortgage Trust: 59,524 shares worth $1.02M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares Preferred and Income Securities ETF, an estimated $2.13M trimmed.

  • Lindbrook Capital's largest Q1 2022 buy was Claros Mortgage Trust: 59,524 shares worth $1.02M.
  • Lindbrook Capital added most to Apple in Q1 2022, an estimated $2.72M increase.
  • Lindbrook Capital's biggest Q1 2022 reduction was iShares Preferred and Income Securities ETF, cutting an estimated $2.13M.
  • Lindbrook Capital fully exited iShares 1-5 Year Investment Grade Corporate Bond ETF in Q1 2022, selling an estimated $524K.
  • Lindbrook Capital's ten largest holdings make up 47% of its $648M portfolio in Q1 2022.
  • Lindbrook Capital opened 549 new positions and closed 135 in Q1 2022.
  • Lindbrook Capital's portfolio value fell 1.4% quarter-over-quarter to $648M.

Based on Lindbrook Capital's 13F filing for Q1 2022, filed 21 Apr 2022.